Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients
- 2 August 2001
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Obesity
- Vol. 25 (8) , 1101-1107
- https://doi.org/10.1038/sj.ijo.0801636
Abstract
International Journal of Obesity is a monthly, multi-disciplinary forum for papers describing basic, clinical and applied studies in biochemistry, genetics and nutrition, together with molecular, metabolic, psychological and epidemiological aspects of obesity and related disordersKeywords
This publication has 30 references indexed in Scilit:
- Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesityMetabolism, 1996
- Insulin Resistance and Obesity: The role of fat distribution patternDiabetes Care, 1996
- Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.BMJ, 1991
- Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependentThe American Journal of Clinical Nutrition, 1990
- The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDMDiabetes, 1988
- Growth Hormone Administration Conserves Lean Body Mass during Dietary Restriction in Obese Subjects*Journal of Clinical Endocrinology & Metabolism, 1987
- Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesityMetabolism, 1987
- The Effect of Growth Hormone on Glucose Metabolism and Insulin Secretion in Man*Journal of Clinical Endocrinology & Metabolism, 1982
- Insulin‐stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose.The Journal of Physiology, 1975
- Weight Loss during Fasting: Implications for the ObeseThe American Journal of Clinical Nutrition, 1970